Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
Medical City Dallas Hospital
mi
from
Dallas, TX
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
The University of Texas Health Science Center at Houston/Memorial Hermann Texas Medical Center
mi
from
Houston, TX
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
The University of Texas Health Science Center at Houston/Memorial Hermann Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Salt Lake City, UT
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
St. Paul's Hospital, Providence Health Care
mi
from
Vancouver,
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
St. Paul's Hospital, Providence Health Care
mi
from
Vancouver,
Click here to add this to my saved trials
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated:  12/31/1969
Washington Hospital Center (WHC)
mi
from
Washington,
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve
PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.
Status: Enrolling
Updated: 12/31/1969
Washington Hospital Center (WHC)
mi
from
Washington,
Click here to add this to my saved trials
Intra-articular Local Anesthetic Injection and Hematoma Aspiration
The Effect of Intra-articular Local Anesthetic Injection and Hematoma Aspiration on Pain and Narcotic Analgesia Use Following Tibial Plateau Fractures
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Intra-articular Local Anesthetic Injection and Hematoma Aspiration
The Effect of Intra-articular Local Anesthetic Injection and Hematoma Aspiration on Pain and Narcotic Analgesia Use Following Tibial Plateau Fractures
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Status: Enrolling
Updated:  12/31/1969
UAB Department of Anesthesiology and Perioperative Medicine
mi
from
Birmingham, AL
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Status: Enrolling
Updated: 12/31/1969
UAB Department of Anesthesiology and Perioperative Medicine
mi
from
Birmingham, AL
Click here to add this to my saved trials
Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy
Systemic Gene Delivery Phase I/IIa Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MHCK7.Micro-dystrophin
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy
Systemic Gene Delivery Phase I/IIa Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MHCK7.Micro-dystrophin
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy
Systemic Gene Delivery Phase I/IIa Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MHCK7.Micro-dystrophin
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy
Systemic Gene Delivery Phase I/IIa Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MHCK7.Micro-dystrophin
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis
Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis - Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis
Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis - Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures
Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures
Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Zip Arthroplasty Patient Satisfaction Evaluation
Zip Arthroplasty Patient Satisfaction Evaluation
Status: Enrolling
Updated:  12/31/1969
Montgomery Orthopaedics Associates
mi
from
Norristown, PA
Zip Arthroplasty Patient Satisfaction Evaluation
Zip Arthroplasty Patient Satisfaction Evaluation
Status: Enrolling
Updated: 12/31/1969
Montgomery Orthopaedics Associates
mi
from
Norristown, PA
Click here to add this to my saved trials
The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Rebecca Martin, OTR/L, OTD, CPAM
mi
from
Baltimore, MD
The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Rebecca Martin, OTR/L, OTD, CPAM
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated:  12/31/1969
Indiana University Health North Hospital
mi
from
Carmel, IN
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated: 12/31/1969
Indiana University Health North Hospital
mi
from
Carmel, IN
Click here to add this to my saved trials
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Hospital
mi
from
Indianapolis, IN
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated:  12/31/1969
Spring Mill Medical Center
mi
from
Indianapolis, IN
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Single Center, Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias
Status: Enrolling
Updated: 12/31/1969
Spring Mill Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated:  12/31/1969
Colorado Joint Replacement
mi
from
Denver, CO
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated: 12/31/1969
Colorado Joint Replacement
mi
from
Denver, CO
Click here to add this to my saved trials
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated:  12/31/1969
Cardinal Orthopaedic Institute
mi
from
Columbus, OH
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated: 12/31/1969
Cardinal Orthopaedic Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Alexandria, VA
36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement
Delta Ceramax 36 mm Ceramic-on-Ceramic Acetabular Cup Prosthesis Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Performance and Nutrition Program for Athletes in Adaptive Sports
The Effectiveness of a Performance and Nutrition Program for Athletes in Adaptive Sports
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Performance and Nutrition Program for Athletes in Adaptive Sports
The Effectiveness of a Performance and Nutrition Program for Athletes in Adaptive Sports
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Status: Enrolling
Updated:  12/31/1969
University of Toledo Medical Center
mi
from
Toledo, OH
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Status: Enrolling
Updated: 12/31/1969
University of Toledo Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Status: Enrolling
Updated:  12/31/1969
CHU de Québec - Université Laval
mi
from
Québec,
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Status: Enrolling
Updated: 12/31/1969
CHU de Québec - Université Laval
mi
from
Québec,
Click here to add this to my saved trials
Self Digital Photography for Assessing Elbow Range of Motion
Validation of Self Digital Photography for Assessing Elbow Range of Motion
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Self Digital Photography for Assessing Elbow Range of Motion
Validation of Self Digital Photography for Assessing Elbow Range of Motion
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital
mi
from
Cleveland, OH
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)
Prospective Evaluation of Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)
Prospective Evaluation of Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado Center for Cancer and Blood Disorders
mi
from
Aurora, CO
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado Center for Cancer and Blood Disorders
mi
from
Aurora, CO
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Child Neurology Center of Northwest Florida
mi
from
Gulf Breeze, FL
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Child Neurology Center of Northwest Florida
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research
mi
from
Saint Louis, MO
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Childrens Medical Center Dallas, Texas
mi
from
Dallas, TX
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Childrens Medical Center Dallas, Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials